ICCC
IMMUCELL CORP
Latest Form 4:Purchase$76Kbyte Boekhorst Paul Francis Olivier (President and CEO) · filed Jun 22, 2026
IMMUCELL CORP (ICCC) has 3 SEC Form 4 filings (5 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 22, 2026.
The most active filer is President and CEO te Boekhorst Paul Francis Olivier with 3 filings.
- Industry:Biotechnology
- CEO:F. Olivier Te Boekhorst
- Employees:69
- HQ:Portland, ME, US
- IPO:1987-05-05
Insider Buying
$107K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$90.9M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
te Boekhorst Paul Francis OlivierFirst in 7 months | President and CEO | Purchase | 8,000 | $76K | Jun 22 | SEC ↗ |
te Boekhorst Paul Francis OlivierFirst filing | President and CEO | Purchase | 3,598 | $18K | Dec 4 | SEC ↗ |
te Boekhorst Paul Francis OlivierFirst filing | President and CEO | Purchase | 2,432 | $13K | Dec 4 | SEC ↗ |
Related companies
IMMUCELL CORP is in the Healthcare sector.